Korean Real-world Data on Unresectable Stage III Non-Small Cell Lung Cancer Patients Treated with Durvalumab after Chemoradiotherapy

被引:0
|
作者
Oh, H. -J. [1 ,2 ]
Park, C. -K. [1 ,2 ]
Kim, Y. -C. [1 ,2 ]
Kim, Y. -H. [1 ,2 ]
Ahn, S. -J. [1 ,2 ]
Jeong, W. G. [1 ,2 ]
Lee, J. Y. [1 ,2 ]
Lee, J. C. [3 ]
Choi, C. M. [3 ]
Ji, W. [3 ]
Song, S. Y. [3 ]
Choi, J. [3 ,4 ]
Lee, S. Y. [4 ,5 ]
Kim, H. [4 ]
Lee, S. Y. [4 ,5 ]
Park, J. [5 ]
Yoon, S. H. [6 ]
Joo, J. H. [6 ]
Oh, I. -J. [1 ,2 ]
机构
[1] Chonnam Natl Univ, Sch Med, Jeonnam, South Korea
[2] Hwasun Hosp, Jeonnam, South Korea
[3] Univ Ulsan, Coll Med, Asan Med Cenc, Seoul, South Korea
[4] Korea Univ, Coll Med, Guro Hosp, Seoul, South Korea
[5] Kyungpook Natl Univ, Sch Med, Daegu, South Korea
[6] Pusan Natl Univ, Sch Med, Yangsan Hosp, Gyeongnam, South Korea
关键词
real-world data; chemoradiotherapy; durvalumab;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P1.28-12
引用
收藏
页码:S294 / S295
页数:2
相关论文
共 50 条
  • [1] Durvalumab After Chemoradiotherapy in Patients With Unresectable Stage III Non-Small Cell Lung Cancer
    Mooradian, Meghan J.
    Cai, Ling
    Wang, Alice
    Qiao, Yao
    Chander, Pratibha
    Whitaker, Ryan M.
    JAMA NETWORK OPEN, 2024, 7 (04) : e247542
  • [2] Consolidation treatment of durvalumab after chemoradiation in real-world patients with stage III unresectable non-small cell lung cancer
    Chu Chia-Hsun
    Chiu Tzu-Hsuan
    Wang Chin-Chou
    Chang Wen-Chen
    Huang Allen Chung-Cheng
    Liu Chien-Ying
    Wang Chih-Liang
    Ko Ho-Wen
    Chung Fu-Tsai
    Hsu Ping-Chih
    Guo Yi-Ke
    Kuo, Chih-Hsi S.
    Yang Cheng-Ta
    THORACIC CANCER, 2020, 11 (06) : 1541 - 1549
  • [3] Real-world experience of consolidation durvalumab after concurrent chemoradiotherapy in stage III non-small cell lung cancer
    Huang, Yiqing
    Zhao, Joseph J.
    Soon, Yu Yang
    Wong, Alvin
    Aminkeng, Folefac
    Ang, Yvonne
    Asokumaran, Yugarajah
    Low, Jia Li
    Lee, Matilda
    Choo, Joan R. E.
    Chan, Gloria
    Kee, Adrian
    Tay, Sen Hee
    Goh, Boon Cher
    Soo, Ross A.
    THORACIC CANCER, 2022, 13 (22) : 3152 - 3161
  • [4] Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KR
    Park, Cheol-Kyu
    Oh, Hyung-Joo
    Kim, Young-Chul
    Kim, Yong-Hyub
    Ahn, Sung-Ja
    Jeong, Won Gi
    Lee, Jeong Yeop
    Lee, Jae Cheol
    Choi, Chang Min
    Ji, Wonjun
    Song, Si Yeol
    Choi, Juwhan
    Lee, Sung Yong
    Kim, Hakyoung
    Lee, Shin Yup
    Park, Jongmoo
    Yoon, Seong Hoon
    Joo, Ji Hyeon
    Oh, In-Jae
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (08) : 1042 - 1054
  • [5] Real-Life Study of Patients with Unresectable Stage III Non-Small Cell Lung Cancer Treated with Chemoradiotherapy Followed by Durvalumab
    Tuller, M.
    Buela, G.
    Ferreira, Y.
    Antivero, A.
    Lupinacci, L.
    Basbus, L.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S607 - S608
  • [6] Real-world outcomes of chemoradiotherapy for unresectable Stage III non-small cell lung cancer: The SOLUTION study
    Horinouchi, Hidehito
    Atagi, Shinji
    Oizumi, Satoshi
    Ohashi, Kadoaki
    Kato, Tomohiro
    Kozuki, Toshiyuki
    Seike, Masahiro
    Sone, Takashi
    Sobue, Tomotaka
    Tokito, Takaaki
    Harada, Hideyuki
    Maeda, Tadashi
    Mio, Tadashi
    Shirosaka, Ikue
    Hattori, Kana
    Shin, Eisei
    Murakami, Haruyasu
    CANCER MEDICINE, 2020, 9 (18): : 6597 - 6608
  • [7] Durvalumab after chemoradiotherapy in stage III non-small cell lung cancer
    Tomasini, Pascale
    Greillier, Laurent
    Boyer, Arnaud
    Jeanson, Arnaud
    Barlesi, Fabrice
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S1032 - S1036
  • [8] Real-World Experience of Patients with Inoperable, Stage III Non-small-Cell Lung Cancer Treated with Durvalumab after Chemoradiotherapy: Indian Experience
    Noronha, Vanita
    Talreja, Vikas T.
    Patil, Vijay
    Joshi, Amit
    Menon, Nandini
    Mahajan, Abhishek
    Janu, Amit
    Prabhash, Kumar
    SOUTH ASIAN JOURNAL OF CANCER, 2020, 9 (03) : 180 - 182
  • [9] Real world data of durvalumab consolidation after chemoradiotherapy in stage III non-small-cell lung cancer
    Jung, Hyun Ae
    Noh, Jae Myoung
    Sun, Jong-Mu
    Lee, Se-Hoon
    Ahn, Jin Seok
    Ahn, Myung-Ju
    Pyo, Hongryull
    Ahn, Yong Chan
    Park, Keunchil
    LUNG CANCER, 2020, 146 : 23 - 29
  • [10] First Real-World Data on Unresectable Stage III NSCLC Patients Treated with Durvalumab after Chemoradiotherapy in Asia Area
    Kuo, C.
    Yang, T. Y.
    Wang, C. C.
    Hua, C. C.
    Hsia, T. C.
    Chiang, C. L.
    Ko, J. C.
    Tsai, C. L.
    Su, P. L.
    Su, J.
    Ho, C. C.
    Chang, G. C.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S265 - S266